Toripalimab injection (JS001): Clinical Trials

1 trial of Toripalimab injection (JS001), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Suspended 1

Follow Toripalimab injection (JS001): new trials by email Literature Review of Toripalimab injection (JS001) trials Research Report on Toripalimab injection (JS001)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Toripalimab injection (JS001), Paclitaxel, Albumin-Bound, Radiotherapy - Esophageal Squamous Cell Carcinoma
Phase 2SuspendedZhejiang Cancer Hospital1002019-09-072021-02-23

Conditions studied

Esophageal Squamous Cell Carcinoma (1)

Sponsors

Zhejiang Cancer Hospital (1)

Countries

China (1)

Top investigators

Chen Ming, MD (1)  ·  Yujin Xu, MD (1)